モチヅキ　マキコ   Mochidzuki Makiko   望月　牧子    所属   医学部 医学科    職種   助教
論文種別	原著
言語種別	英語
査読の有無	査読あり
表題	Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders.
掲載誌名	正式名：The Journal of experimental medicine 略　 称：J Exp Med ISSNコード：15409538/00221007
掲載区分	国外
巻・号・頁	210(12),pp.2627-39
著者・共著者	Muto Tomoya, Sashida Goro, Oshima Motohiko, Wendt George R, Mochizuki-Kashio Makiko, Nagata Yasunobu, Sanada Masashi, Miyagi Satoru, Saraya Atsunori, Kamio Asuka, Nagae Genta, Nakaseko Chiaki, Yokote Koutaro, Shimoda Kazuya, Koseki Haruhiko, Suzuki Yutaka, Sugano Sumio, Aburatani Hiroyuki, Ogawa Seishi, Iwama Atsushi
発行年月	2013/11
概要	Polycomb group (PcG) proteins are essential regulators of hematopoietic stem cells. Recent extensive mutation analyses of the myeloid malignancies have revealed that inactivating somatic mutations in PcG genes such as EZH2 and ASXL1 occur frequently in patients with myelodysplastic disorders including myelodysplastic syndromes (MDSs) and MDS/myeloproliferative neoplasm (MPN) overlap disorders (MDS/MPN). In our patient cohort, EZH2 mutations were also found and often coincided with tet methylcytosine dioxygenase 2 (TET2) mutations. Consistent with these findings, deletion of Ezh2 alone was enough to induce MDS/MPN-like diseases in mice. Furthermore, concurrent depletion of Ezh2 and Tet2 established more advanced myelodysplasia and markedly accelerated the development of myelodysplastic disorders including both MDS and MDS/MPN. Comprehensive genome-wide analyses in hematopoietic progenitor cells revealed that upon deletion of Ezh2, key developmental regulator genes were kept transcriptionally repressed, suggesting compensation by Ezh1, whereas a cohort of oncogenic direct and indirect polycomb targets became derepressed. Our findings provide the first evidence of the tumor suppressor function of EZH2 in myeloid malignancies and highlight the cooperative effect of concurrent gene mutations in the pathogenesis of myelodysplastic disorders.
DOI	10.1084/jem.20131144
PMID	24218139